0000950103-24-011229.txt : 20240730 0000950103-24-011229.hdr.sgml : 20240730 20240730210155 ACCESSION NUMBER: 0000950103-24-011229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240726 FILED AS OF DATE: 20240730 DATE AS OF CHANGE: 20240730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Venker Eric CENTRAL INDEX KEY: 0001801917 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 241159590 MAIL ADDRESS: STREET 1: C/O ROIVANT SCIENCES, INC. STREET 2: 320 WEST 37TH STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 dp2015709_4-venker.xml FORM 4 X0508 4 2024-07-26 0 0001635088 Roivant Sciences Ltd. ROIV 0001801917 Venker Eric C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM 0 1 0 0 President & COO 0 Common Shares 2024-07-26 4 A 0 204000 0 A 650307 D Stock Option (Right to Buy) 10.80 2024-07-26 4 A 0 409000 0 A 2034-07-25 Common Shares 409000 409000 D Reflects an award of restricted stock units with respect to Common Shares, with a vesting commencement date of April 20, 2024, which service-vest (i) 25% on May 20, 2025 and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date. Reflects an award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date. By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker 2024-07-30